While the 10% tariff on Chinese goods won’t have too much impact on branded drugs, generics are struggling to pivot.
The 340B Drug Pricing Program allows certain hospitals and clinics to buy medications given to outpatients at a discount, ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give upfront ...
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...
U.S. hospitals and generic drugmakers urge President Trump to exempt medical goods from new tariffs on Chinese imports. They warn that these tariffs could cause medicine shortages and increase prices.
Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...
President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...
President Donald Trump's steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the U.S. and ...
The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...
President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback